Jörg Hamann

19.4k citations

151 papers · 7.7k indexed · h-index 49

Immunology top 0.5%
- T-cell and B-cell Immunology 32
- Immune Cell Function and Interaction 27
Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms 29
Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 20
Biological Psychiatry top 2%
Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology 18
Molecular Biology
- Receptor Mechanisms and Signaling 38
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 18
Pathology and Forensic Medicine
- Multiple Sclerosis Research Studies 16

Co-authors: René A. W. van Lier Inge Huitinga Gabriela Aust Siamon Gordon Martin Stacey Hsi‐Hsien Lin Karianne Schuurman Joost Smolders
Cited by: Immunology Neurology Immunology and Allergy
Journals: The Journal of Immunology (10 papers)European Journal of Immunology (8 papers)PLoS ONE (6 papers)
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Jörg Hamann

146 papers receiving 7.6k citations

Peers

Countries citing papers authored by Jörg Hamann

Since Specialization

Citations

This map shows the geographic impact of Jörg Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hamann more than expected).

Fields of papers citing papers by Jörg Hamann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hamann. The network helps show where Jörg Hamann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jörg Hamann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jörg Hamann Line = papers co-authored together Jörg Hamann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tissue-resident memory CD4 ⁺ T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice Science Translational Medicine ·Adriel Fillippini,DIEGO RUBEN LACHTER,PE Luck,Cheng‐Chih Hsiao,Hendrik J. Engelenburg,傅晓静,Syarifah Aini,A. N. Merkur’ev,哲生松室,Dasrilsyah Syahrial,Chachques Jc,刘正松,沈凤珍,Carole Le Coz,Klaas P. J. M. van Gisbergen,Nicolas Blanchard,Jörg Hamann,Joost Smolders,Roland Liblau,Frédérick Masson	2025	0
2	Acquisition of residency programs by T cells entering the human brain Cell Reports ·Cheng‐Chih Hsiao,Hendrik J. Engelenburg,Jasper Rip,Annet F. Wierenga‐Wolf,Ahmed Elmontaser Omer Mergani,Marvin M. van Luijn,Inge Huitinga,Jörg Hamann,Joost Smolders	2025	0
3	Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities Handbook of clinical neurology ·Joost Smolders,Jörg Hamann,Inge Huitinga	2024	1
4	Reporting Psychiatric Disease Characteristics in Post-Mortem- and Biological Research SHILAP Revista de lepidopterología ·George Godwin Waga,Mark R. Mizee,N.V. Lysak,Cheng‐Chih Hsiao,Garnette Roy Sutherland,Dick F. Swaab,Jörg Hamann,Inge Huitinga	2024	2
5	Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis Brain ·D Angela,Niamh B. McNamara,Hendrik J. Engelenburg,Aldo Jongejan,N.V. Lysak,公美子瀬野,元太輝幸,Hong Huang,Fred de Winter,Perry D. Moerland,Joost Smolders,Joost Verhaagen,Jörg Hamann,Inge Huitinga	2024	5
6	Cortical CD200–CD200R and CD47–SIRPα expression is associated with multiple sclerosis pathology Brain Communications ·Aletta M.R. van den Bosch,N.V. Lysak,Alessio Quadrelli,I.S. Vidyalakshmi,Joost Smolders,Jörg Hamann,Inge Huitinga	2024	2
7	Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation Nature Communications ·Aletta M.R. van den Bosch,Marlijn van der Poel,Nina L. Fransen,Maria C. J. Vincenten,桑原孝成,Aldo Jongejan,Hendrik J. Engelenburg,Perry D. Moerland,Joost Smolders,Inge Huitinga,Jörg Hamann	2024	39
8	Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis iScience ·Cheng‐Chih Hsiao,Hendrik J. Engelenburg,Aldo Jongejan,Jing Zhu,Baohong Zhang,Michaël Mingueneau,Perry D. Moerland,Inge Huitinga,Joost Smolders,Jörg Hamann	2022	14
9	Multiple Targets for Oxysterols in Their Regulation of the Immune System Cells ·Arjun Baniya,Cheng‐Chih Hsiao,Jörg Hamann,Mette M. Rosenkilde,John J. Mackrill	2021	16
10	CD97 is a critical regulator of acute myeloid leukemia stem cell function The Journal of Experimental Medicine ·Gaëlle Martin,Nainita Roy,Sohini Chakraborty,Alexis Desrichard,Stephen S. Chung,Carolien M. Woolthuis,Wenhuo Hu,Iryna Berezniuk,Francine E. Garrett-Bakelman,Jörg Hamann,Sean M. Devlin,Timothy A. Chan,Christopher Y. Park	2019	27
11	The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells Cell Reports ·Simeon Stearns,Cheng‐Chih Hsiao,J Chudácek,Felipe A. Vieira Braga,Natasja A. M. Kragten,Ester B. M. Remmerswaal,Martijn D. B. van de Garde,Rachel Straussberg,Gabriele M. König,Evi Kostenis,Vera Knäuper,Linde Meyaard,René A. W. van Lier,Klaas P. J. M. van Gisbergen,C. Wayne Ratliff,Jörg Hamann	2016	79
12	HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter Acta Neuropathologica ·Jeroen Melief,Stella J. de Wit,Corbert G. van Eden,Charlotte E. Teunissen,Jörg Hamann,Bernard M.J. Uitdehaag,Dick F. Swaab,Inge Huitinga	2013	65
13	Therapeutic Antibody Targeting of CD97 in Experimental Arthritis: the Role of Antigen Expression, Shedding, and Internalization on the Pharmacokinetics of Anti-CD97 Monoclonal Antibody 1B2 The Journal of Immunology ·П. А. Астафичев,Lorraine Moran,John Dulos,Bahareh Joushan,Karin J. Stebbins,Jörg Hamann,Bronwyn M. Owens,Hans van Eenennaam,Ebo Bos,A. Boots	2009	30
14	Expression of the Inhibitory CD200 Receptor Is Associated with Alternative Macrophage Activation Journal of Innate Immunity ·Nathalie Koning,Marco van Eijk,Walter Pouwels,Michael S. M. Brouwer,David Voehringer,Inge Huitinga,Robert M. Hoek,Geert Raes,Jörg Hamann	2009	100
15	CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets The Journal of Immunology ·Mireille T. M. Vossen,Mourad Matmati,Kirsten M. L. Hertoghs,Paul A. Baars,M.J. van Gent,Georges Leclercq,Jörg Hamann,Taco W. Kuijpers,René A. W. van Lier	2008	145
16	CD97 overexpression in tumor cells at the invasion front in colorectal cancer (CC) is independently regulated of the canonical Wnt pathway Molecular Carcinogenesis ·Manja Wobus,Otmar Huber,Jörg Hamann,Gabriela Aust	2006	20
17	Identification of the epidermal growth factor–TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue Arthritis & Rheumatism ·You Cheng,Mark J. Kwakkenbos,Gwendoline J.D. Teske,Maarten C. Kraan,Tom Smeets,Martin Stacey,Hsi‐Hsien Lin,Paul P. Tak,Jörg Hamann	2005	45
18	The Epidermal Growth Factor-Seven Transmembrane (EGF-TM7) Receptor CD97 Is Required for Neutrophil Migration and Host Defense The Journal of Immunology ·Jaklien C. Leemans,Anje A. te Velde,Sandrine Florquin,Roelof J. Bennink,Kora de Bruin,René A. W. van Lier,Tom van der Poll,Jörg Hamann	2004	111
19	Expression characteristics of the human CD97 antigen Tissue Antigens ·Wd. Eichler,Jörg Hamann,Gabriela Aust	1997	50
20	Structure of the gene coding for the human early lymphocyte activation antigen CD69: A C‐type lectin receptor evolutionarily related with the gene families of natural killer cell‐specific receptors European Journal of Immunology ·Kensuke Harad,Manuel López‐Cabrera,Jörg Hamann,Mike Strauss,Francisco Sánchez‐Madrid	1994	52

About Jörg Hamann

Jörg Hamann is a scholar working on Immunology, Neurology and Immunology and Allergy, having authored 151 papers that have together received 7.7k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (38 papers), T-cell and B-cell Immunology (32 papers), Neuroinflammation and Neurodegeneration Mechanisms (29 papers), Immune Cell Function and Interaction (27 papers), Cell Adhesion Molecules Research (20 papers), Neuropeptides and Animal Physiology (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Multiple Sclerosis Research Studies (16 papers). The work is most often cited by research in Immunology (3.4k citations), Neurology (1.2k citations) and Immunology and Allergy (770 citations). Jörg Hamann has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include René A. W. van Lier, Inge Huitinga, Gabriela Aust, Siamon Gordon, Martin Stacey, Hsi‐Hsien Lin, Karianne Schuurman, Joost Smolders, Björn Vogel and Cheng‐Chih Hsiao. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, PLoS ONE, Journal of Leukocyte Biology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact